The significance of the homozygous CYP2A6 deletion on nicotine metabolism: a new genotyping method of CYP2A6 using a single PCR-RFLP
about
PharmGKB summary: very important pharmacogene information for cytochrome P-450, family 2, subfamily A, polypeptide 6Polymorphisms of CYP2A6 and its practical consequencesThe Prevalence of Self-Reported Smoking and Validation with Urinary Cotinine Among Commercial Drivers in Major Parks in Lagos, NigeriaPrecision Medicine for Tobacco Dependence: Development and Validation of the Nicotine Metabolite RatioEnzyme-linked immunosorbent assay of nicotine metabolitesInterindividual differences in nicotine metabolism and genetic polymorphisms of human CYP2A6.A review and assessment of potential sources of ethnic differences in drug responsiveness.Association of CYP2A6 deletion polymorphism with smoking habit and development of pulmonary emphysema.Differences in drug pharmacokinetics between East Asians and Caucasians and the role of genetic polymorphisms.Frequencies of 23 functionally significant variant alleles related with metabolism of antineoplastic drugs in the chilean population: comparison with caucasian and asian populations.Genetic variability in CYP2A6 and the pharmacokinetics of nicotine.Past and future applications of CYP450-genetic polymorphisms for biomonitoring of environmental toxicants.Genetics of tobacco use.Nicotine dependence pharmacogenetics: role of genetic variation in nicotine-metabolizing enzymesApplications of CYP-450 expression for biomonitoring in environmental healthGenetic polymorphism of enzymes involved in xenobiotic metabolism and the risk of lung cancerCYP2A6 polymorphisms and risk for tobacco-related cancers.Distribution of polymorphic variants of CYP2A6 and their involvement in nicotine addiction.Characterization of a novel CYP2A7/CYP2A6 hybrid allele (CYP2A6*12) that causes reduced CYP2A6 activity.Relation between cotinine in the urine and indices based on self-declared smoking habits.Genetic polymorphisms ofCYP2A6 andCYP2E1 with tobacco smoking is not associated with risk of urothelial cancer.New CYP2A6 gene deletion and conversion variants in a population of Black African descent.CYP2A6*6, a novel polymorphism in cytochrome p450 2A6, has a single amino acid substitution (R128Q) that inactivates enzymatic activity.Determination of coumarin metabolism in Turkish population.Effects of whole deletion of CYP2A6 on nicotine metabolism in humans.Effects of cytochrome P450 (CYP) 2A6 gene deletion and CYP2E1 genotypes on gastric adenocarcinoma.More potent inhibition of human CYP2A6 than mouse CYP2A5 enzyme activities by derivatives of phenylethylamine and benzaldehyde.Differences between Spaniards and Ecuadorians in CYP2A6 allele frequencies: comparison with other populations.Genetics of Tobacco Use.Cytochrome p450 metabolism of betel quid-derived compounds: implications for the development of prevention strategies for oral and pharyngeal cancers.Identification and characterisation of novel polymorphisms in the CYP2A locus: implications for nicotine metabolism.Association of genetic polymorphisms CYP2A6*2 rs1801272 and CYP2A6*9 rs28399433 with tobacco-induced lung Cancer: case-control study in an Egyptian population.
P2860
Q27012807-00A22E4A-EA6A-444B-9354-AD9DB41FCB19Q28362536-87DDBC25-6EE4-4125-82F5-04E010435E9EQ29248942-951630F0-9FE4-469C-9703-7DE12DD83682Q33821233-27F99A69-D6FC-42B9-9B8D-7DF8D0231A3AQ33918098-B40DB9B8-FE3A-4FEB-805A-9F988BBC1139Q35027945-31BB2D74-D9E1-487A-AE79-AC6E9FEEE3E6Q35217493-049F4130-5755-45E7-9DA7-90DDDF4A31DDQ35536013-68119413-89AE-4DD6-8426-B69501346DD3Q35876954-D2975C1F-9C55-429D-8065-F19A8F7598E8Q36365599-4397EC35-A8F8-4F1D-B4CC-8C81A89FF36EQ36989832-5FF03821-91AC-4045-9771-B2FFE5DA02FCQ37000474-6D843162-049E-4115-9017-F1798D89F443Q37164984-5C01F572-EDFD-4EAD-BAE5-50ABD94B8426Q37169244-75E730C8-FF3C-4A00-B446-0D7F0A3AA732Q37232322-44CBDECC-AA93-4C04-B356-19E5E4A60E13Q37296120-C6F9370E-ED3C-4E70-9A95-4F54D6D7B9F7Q37329175-2C4E52C6-ED5E-4FFF-8F52-56310B0177FEQ38683483-85B36C8C-7141-47BA-B4A7-EB5B06AA5582Q40701329-E4354F8B-B6CF-4687-A271-3C1D36860D85Q41861843-306758EE-3E8C-4B1B-B7FA-3412C1F0BCA6Q42062031-73F1D864-57BB-4E32-8EB0-AE21419F1E9CQ42120565-6F408CD8-8579-4F62-911B-DF2013EEEC43Q43559545-E77BD209-45CC-43A5-8AAE-DB25D48A5A8AQ43630476-879E8236-5AD4-4D79-8FD7-134D9BC843A7Q44002892-931C13D0-436F-403B-A96F-A0635130B6F8Q44062521-0167E027-A0C2-4185-A27A-B274C0F57BEEQ44440357-85325E8F-36DC-45F2-AC93-496F7A6C1094Q46436451-E4E0876D-A286-461F-B74F-9D869B6D0000Q46660426-B14DAE6C-A62B-4BEB-8672-36ED1409B2DDQ51370536-5D7F6ECB-5976-45BC-951F-887156DB7E9DQ52277603-06CBB046-CC9B-4B2A-9C00-236BDC9735BBQ53686438-F8A5DB48-9F85-4011-BD96-CEEE244E03F9
P2860
The significance of the homozygous CYP2A6 deletion on nicotine metabolism: a new genotyping method of CYP2A6 using a single PCR-RFLP
description
1999 nî lūn-bûn
@nan
1999 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
The significance of the homozy ...... CYP2A6 using a single PCR-RFLP
@ast
The significance of the homozy ...... CYP2A6 using a single PCR-RFLP
@en
The significance of the homozy ...... CYP2A6 using a single PCR-RFLP
@nl
type
label
The significance of the homozy ...... CYP2A6 using a single PCR-RFLP
@ast
The significance of the homozy ...... CYP2A6 using a single PCR-RFLP
@en
The significance of the homozy ...... CYP2A6 using a single PCR-RFLP
@nl
prefLabel
The significance of the homozy ...... CYP2A6 using a single PCR-RFLP
@ast
The significance of the homozy ...... CYP2A6 using a single PCR-RFLP
@en
The significance of the homozy ...... CYP2A6 using a single PCR-RFLP
@nl
P2093
P356
P1476
The significance of the homozy ...... CYP2A6 using a single PCR-RFLP
@en
P2093
P304
P356
10.1006/BBRC.1999.1182
P407
P577
1999-08-01T00:00:00Z